New Year Bumper Sale @ Rs. 1 X
Tglip M is a prescription medicine that is available as a Tablet. Other than this, Tglip M has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Tglip M is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Tglip M also has some side effects, the most common being Stomach Upset, Difficulty urinating, Hypoglycemia (Low blood sugar level). Apart from the aforementioned side effects, Tglip M can also lead to other problems, which have been listed below. Normally, these side effects of Tglip M are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Tglip M has a Moderate effect for pregnant women and Severe effect on lactating mothers. Warnings related to Tglip M's effects on the liver, heart and kidney, if any, have been listed below.
Tglip M is not recommended if you suffer from certain medical conditions as it can have adverse effects. Congestive Heart Failure (CHF), Anemia, Shock are examples of such conditions. Other conditions have been mentioned below in the Tglip M contraindications section.
Drug interactions for Tglip M have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Tglip M is safe while driving, and is is addictive in nature.
Tglip M is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Tglip M is used -
Severe
Moderate
Mild
Common
Unknown
Is the use of Tglip M safe for pregnant women?
Tglip M may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Tglip M again without your doctor's advice.
Is the use of Tglip M safe during breastfeeding?
Taking Tglip M may lead to serious side effects if you are breastfeeding. Tglip M should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Tglip M on the Kidneys?
There is no research available on the side effects of Tglip M on kidney. Therefore, its impact is unknown.
What is the effect of Tglip M on the Liver?
Information about safety of Tglip M for the liver is not available since scientific research on this is yet to be done.
What is the effect of Tglip M on the Heart?
Information about safety of Tglip M for heart is not available since scientific research on this is yet to be done.
Tglip M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tglip M unless your doctor advises you to do so -
Is this Tglip M habit forming or addictive?
No, you will not get addicted to Tglip M.
Interaction between Food and Tglip M
Information is not available on the interaction of any foods with Tglip M, due to a lack of research on this.
Interaction between Alcohol and Tglip M
Information about the interaction of Tglip M and alcohol is not currently available because this topic has not been researched yet.
No, you should not take alcohol with Tglip M, because it can cause serious side effects which includes hypoglycemia (low blood sugar). The risk of hypoglycemia is higher when you're drinking and taking Tglip M than if you're just taking Tglip M. Some of the signs of hypoglycemia include dizziness, confusion, and drowsiness.
Lactic acidosis associated with Tglip M treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of Tglip M induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
Tglip M is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
Yes, Tglip M can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with metformin. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia, always keep glucose-rich food with you.
Tglip M contain metformin, is an oral antidiabetic drug which belongs to the class of biguanide. It is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. Moreover, it also reduces the risk of cardiovascular complications of diabetes.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826